204 related articles for article (PubMed ID: 36006479)
21. A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice.
Engel JA; Nylander I; Jerlhag E
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2364-71. PubMed ID: 26508707
[TBL] [Abstract][Full Text] [Related]
22. Placebo effect and dopamine release.
de la Fuente-Fernández R; Lidstone S; Stoessl AJ
J Neural Transm Suppl; 2006; (70):415-8. PubMed ID: 17017561
[TBL] [Abstract][Full Text] [Related]
23. The biochemical bases of the placebo effect.
de la Fuente-Fernández R; Stoessl AJ
Sci Eng Ethics; 2004 Jan; 10(1):143-50. PubMed ID: 14986780
[TBL] [Abstract][Full Text] [Related]
24. Nocebo and lessebo effects.
A Mestre T
Int Rev Neurobiol; 2020; 153():121-146. PubMed ID: 32563285
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of placebo responses in humans.
Peciña M; Zubieta JK
Mol Psychiatry; 2015 Apr; 20(4):416-23. PubMed ID: 25510510
[TBL] [Abstract][Full Text] [Related]
26. The role of dopamine in overcoming aversion with exercise.
Greenwood BN
Brain Res; 2019 Jun; 1713():102-108. PubMed ID: 30171838
[TBL] [Abstract][Full Text] [Related]
27. Opioid and nondopamine reward circuitry and state-dependent mechanisms.
Fujita M; Ide S; Ikeda K
Ann N Y Acad Sci; 2019 Sep; 1451(1):29-41. PubMed ID: 29512887
[TBL] [Abstract][Full Text] [Related]
28. Psychological Placebo and Nocebo Effects on Pain Rely on Expectation and Previous Experience.
Reicherts P; Gerdes AB; Pauli P; Wieser MJ
J Pain; 2016 Feb; 17(2):203-14. PubMed ID: 26523863
[TBL] [Abstract][Full Text] [Related]
29. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
Chen X; Voets S; Jenkinson N; Galea JM
J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
[TBL] [Abstract][Full Text] [Related]
30. Understanding placebo and nocebo responses for pain management.
Colloca L; Grillon C
Curr Pain Headache Rep; 2014 Jun; 18(6):419. PubMed ID: 24771206
[TBL] [Abstract][Full Text] [Related]
31. Distinct Roles of Opioid and Dopamine Systems in Lateral Hypothalamic Intracranial Self-Stimulation.
Ide S; Takahashi T; Takamatsu Y; Uhl GR; Niki H; Sora I; Ikeda K
Int J Neuropsychopharmacol; 2017 May; 20(5):403-409. PubMed ID: 28031268
[TBL] [Abstract][Full Text] [Related]
32. [Placebo effect in Parkinson's disease].
Miwa H
Brain Nerve; 2007 Feb; 59(2):139-46. PubMed ID: 17380778
[TBL] [Abstract][Full Text] [Related]
33. Would the elderly be better off if they were given more placebos?
Cherniack EP
Geriatr Gerontol Int; 2010 Apr; 10(2):131-7. PubMed ID: 20100289
[TBL] [Abstract][Full Text] [Related]
34. Imaging the placebo response: a neurofunctional review.
Faria V; Fredrikson M; Furmark T
Eur Neuropsychopharmacol; 2008 Jul; 18(7):473-85. PubMed ID: 18495442
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study.
da Silva Alves F; Bakker G; Schmitz N; Abeling N; Hasler G; van der Meer J; Nederveen A; de Haan L; Linszen D; van Amelsvoort T
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1577-86. PubMed ID: 23978392
[TBL] [Abstract][Full Text] [Related]
36. Nature of the placebo and nocebo effect in relation to functional neurologic disorders.
Carlino E; Piedimonte A; Benedetti F
Handb Clin Neurol; 2016; 139():597-606. PubMed ID: 27719874
[TBL] [Abstract][Full Text] [Related]
37. Nocebo effects on motor performance: A systematic literature review.
Horváth Á; Köteles F; Szabo A
Scand J Psychol; 2021 Oct; 62(5):665-674. PubMed ID: 34145580
[TBL] [Abstract][Full Text] [Related]
38. Involvement of basal ganglia and orbitofrontal cortex in goal-directed behavior.
Hollerman JR; Tremblay L; Schultz W
Prog Brain Res; 2000; 126():193-215. PubMed ID: 11105648
[TBL] [Abstract][Full Text] [Related]
39. The placebo-nocebo response: controversies and challenges from clinical and research perspective.
Jakovljevic M
Eur Neuropsychopharmacol; 2014 Mar; 24(3):333-41. PubMed ID: 24393653
[TBL] [Abstract][Full Text] [Related]
40. How Reward and Aversion Shape Motivation and Decision Making: A Computational Account.
Verharen JPH; Adan RAH; Vanderschuren LJMJ
Neuroscientist; 2020 Feb; 26(1):87-99. PubMed ID: 30866712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
